How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life Experience

BACKGROUND: Hepatocellular carcinoma is a relevant cause of mortality worldwide, mainly among patients who have a prior liver disease. In spite of clear recommendations regarding surveillance and screening methods, most patients are still diagnosed only when they are no longer candidates to curative...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawanami, Gustavo Hideki, Katsuda, Leopoldo, Rocha, Thiara Barcelos, da Silva Yamashiro, Fabio, Pelafsky, Leonardo, Qi, Xingshun, Romeiro, Fernando Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878098/
https://www.ncbi.nlm.nih.gov/pubmed/33614533
http://dx.doi.org/10.1155/2021/6219896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878098/
https://www.ncbi.nlm.nih.gov/pubmed/33614533
http://dx.doi.org/10.1155/2021/6219896

Ejemplares similares